Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(9)
DRUG(2)
BIOLOGICAL(1)
PROCEDURE(1)
Cyclophosphamide
2 trials
phase_2phase_3
dartmouthhitchcock-medical-center
Fludarabine
2 trials
phase_1phase_3
dartmouthhitchcock-medical-center
Peripheral Blood Transplant
1 trial
phase_3
dartmouthhitchcock-medical-center
Ex-vivo expanded effector cells
1 trial
phase_2
dartmouthhitchcock-medical-center
g-csf
1 trial
phase_3
dartmouthhitchcock-medical-center
Total Body Irradiation
1 trial
phase_3
dartmouthhitchcock-medical-center
Busulfan
1 trial
phase_1
dartmouthhitchcock-medical-center
Rabbit ATG
1 trial
phase_1
dartmouthhitchcock-medical-center

+3 more interventions

11 unique interventions4 categories

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31

Trial Status

Completed4
Terminated1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT03480360Phase 3Completed
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
PrincipalinvestigatorStart date: 2018-03-28
NCT02916979Phase 1Completed
Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG
Leukemia, LymphoidLeukemia, MyeloidLymphoma, Malignant+4 more
PrincipalinvestigatorStart date: 2016-09-06
NCT00439465Phase 2Completed
Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
MyelomaTransplant-eligible Patients
Principalinvestigator
NCT01382615Terminated
Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
Multiple Myeloma
Principalinvestigator
NCT02139280Phase 2Completed
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy
Hematologic Malignancies
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+6 more
Similarity Score16%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, Non-HodgkinLeukemia, Myeloid, Acute+5 more
Similarity Score14%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+3 more
Similarity Score11%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell+3 more
Similarity Score11%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteHematologic NeoplasmsLymphoma+2 more

Worked with same sponsors:

The Leukemia and Lymphoma Society
Similarity Score9%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematologic Neoplasms+1 more
Similarity Score7%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-CellLymphoma+1 more
Similarity Score7%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcuteHematologic Neoplasms+1 more
Similarity Score7%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLeukemia, Myeloid, AcuteWaldenstrom Macroglobulinemia
Similarity Score5%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellLymphomaHematologic Neoplasms
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT03480360Phase 3PrincipalInvestigator

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more
Completed
NCT02916979Phase 1PrincipalInvestigator

Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

Leukemia, LymphoidLeukemia, MyeloidLymphoma, Malignant+4 more
Completed
NCT00439465Phase 2PrincipalInvestigator

Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

MyelomaTransplant-eligible Patients
Completed
NCT01382615PrincipalInvestigator

Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research

Multiple Myeloma
Terminated
NCT02139280Phase 2PrincipalInvestigator

Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy

Hematologic Malignancies
Completed

All 5 trials loaded